OFFICIAL LAUNCH OF THE HEPA PLUS RESEARCH AWARDS SCHEME Date: July 23, 2026

Ebenage Herbal Production and Consult, in partnership with the Department of Herbal Medicine at Kwame Nkrumah University of Science and Technology (KNUST), is pleased to announce the official launch of the Hepa Plus Research Awards Scheme, effective July 23, 2026.

This pioneering initiative marks a major step forward in the advancement of herbal medicine across Africa-underscoring a firm commitment to scientific inquiry, innovation, and evidence-based healthcare. The Awards Scheme is designed to empower students, researchers, and health practitioners to pursue transformative research that deepens the understanding, development, and real-world application of herbal therapies.

The programme is seeded with an initial fund of **USD $3,000**, contributed equally from Ebenage Herbal's three flagship products-**Hepa Plus**, **Pavi**, and **Plasmox**-with $1,000 allocated from each brand. This investment reflects our belief that the future of healthcare depends on continuous reinvestment in research and discovery.

Core Objectives of the Hepa Plus Research Awards Scheme:

• Promote high-quality scientific research that supports evidence-based herbal medicine.

• Empower emerging scholars and practitioners to develop innovative healthcare solutions.

• Translate research findings into sustainable enterprises, jobs, and broader economic value.

• Deepen collaboration between academia and industry, bridging the gap between laboratory science and community health impact.

Our Vision

We envision an Africa that leads the world in evidence-based herbal medicine-where indigenous knowledge, scientific rigor, and innovation converge to deliver safe, effective, and globally competitive healthcare solutions.

At Ebenage Herbal Production and Consult, we are convinced that lasting progress in healthcare must be rooted in credible science. Through this Awards Scheme, we are investing not only in research, but in the next generation of thinkers and change-makers whose discoveries will transform lives, strengthen health systems, and contribute meaningfully to national and continental development.

This initiative further reinforces our enduring dedication to healthcare through our trusted brands-Hepa Plus, Pavi, and Plasmox-while championing education, scientific excellence, and community wellbeing across Ghana and beyond.

With the launch of the Hepa Plus Research Awards Scheme, we embark on a long-term journey to elevate herbal medicine through rigorous research, strategic partnerships, and purposeful innovation.

Together, we are building a healthier future-powered by science, driven by research, and inspired by nature.